Del. Justices Reverse GSK's $57M Lupus Drug Patent Loss
The Delaware Supreme Court reversed a trial court decision Wednesday that put pharma giant GSK on the hook for $57 million in damages over its decision to halt royalty payments on...To view the full article, register now.
Already a subscriber? Click here to view full article